Terms: = Liver cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Diagnosis
12 results:
1. ZNF204P is a stemness-associated oncogenic long non-coding RNA in hepatocellular carcinoma.
Hwang JH; Lee J; Choi WY; Kim MJ; Lee J; Chu KHB; Kim LK; Kim YJ
BMB Rep; 2022 Jun; 55(6):281-286. PubMed ID: 35168700
[TBL] [Abstract] [Full Text] [Related]
2. A comprehensive assessment of the impact of a colorectal cancer screening program in a northern Italian area.
Pancheri S; Pertile R; Armelao F; Rizzello RV; Piffer S; Zorzi M; Guzzinati S; Ferro A; Mantovani W; de Pretis G
Dig Liver Dis; 2022 Mar; 54(3):400-406. PubMed ID: 33853757
[TBL] [Abstract] [Full Text] [Related]
3. Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor oct4.
Ye C; Zhang X; Chen X; Cao Q; Zhang X; Zhou Y; Li W; Hong L; Xie H; Liu X; Cao H; Wang YJ; Kang B
Cell Oncol (Dordr); 2020 Apr; 43(2):279-295. PubMed ID: 31848930
[TBL] [Abstract] [Full Text] [Related]
4. Primary yolk sac tumour of the prostate mimicking small round blue cell tumour.
Gui H; Kolster RA; Palmer MB; Brooks JS; Zhang M; Husson MA
Curr Oncol; 2019 Oct; 26(5):e707. PubMed ID: 31708666
[TBL] [Abstract] [Full Text] [Related]
5. Long non-coding RNA HOXA-AS2 promotes the migration, invasion and stemness of bladder cancer via regulating miR-125b/Smad2 axis.
Wang F; Wu D; Chen J; Chen S; He F; Fu H; Wu Q; Liu S; Li X; Wang W
Exp Cell Res; 2019 Feb; 375(1):1-10. PubMed ID: 30412716
[TBL] [Abstract] [Full Text] [Related]
6. Renal Cell Carcinoma, Unclassified with Medullary Phenotype and Synchronous Renal Clear Cell Carcinoma Present in a Patient with No Sickle Cell Trait/Disease: Diagnostic and Therapeutic Challenges.
Lai JZ; Lai HH; Cao D
Anticancer Res; 2018 Jun; 38(6):3757-3761. PubMed ID: 29848739
[TBL] [Abstract] [Full Text] [Related]
7. Impact of Organic Cation Transporters (OCT-SLC22A) on Differential diagnosis of Intrahepatic Lesions.
Visentin M; van Rosmalen BV; Hiller C; Bieze M; Hofstetter L; Verheij J; Kullak-Ublick GA; Koepsell H; Phoa SS; Tamai I; Bennink RJ; van Gulik TM; Stieger B
Drug Metab Dispos; 2017 Feb; 45(2):166-173. PubMed ID: 27903597
[TBL] [Abstract] [Full Text] [Related]
8. ZIC2-dependent oct4 activation drives self-renewal of human liver cancer stem cells.
Zhu P; Wang Y; He L; Huang G; Du Y; Zhang G; Yan X; Xia P; Ye B; Wang S; Hao L; Wu J; Fan Z
J Clin Invest; 2015 Oct; 125(10):3795-808. PubMed ID: 26426078
[TBL] [Abstract] [Full Text] [Related]
9. Newly available antibodies with practical applications in surgical pathology.
Chan JK
Int J Surg Pathol; 2013 Dec; 21(6):553-72. PubMed ID: 24225578
[TBL] [Abstract] [Full Text] [Related]
10. Late recurrence of hepatocellular carcinoma after liver transplantation: is an active surveillance for recurrence needed?
Castroagudín JF; Molina-Pérez E; Ferreiro-Iglesias R; Abdulkader I; Otero-Antón E; Tomé S; Varo-Pérez E
Transplant Proc; 2012; 44(6):1565-7. PubMed ID: 22841215
[TBL] [Abstract] [Full Text] [Related]
11. Increased expression of oct4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma.
Dong Z; Zeng Q; Luo H; Zou J; Cao C; Liang J; Wu D; Liu L
Pathol Res Pract; 2012 Sep; 208(9):527-33. PubMed ID: 22824146
[TBL] [Abstract] [Full Text] [Related]
12. Doubling time of circulating cea and its relation to survival of patients with recurrent colorectal cancer.
Staab HJ; Anderer FA; Hornung A; Stumpf E; Fischer R
Br J Cancer; 1982 Nov; 46(5):773-81. PubMed ID: 7171456
[TBL] [Abstract] [Full Text] [Related]
